TMSB10 and plasma cell myeloma: Paradoxically, Tβ4 and Tβ10 may be involved in cancer degeneration, as reports have indicated that Tβ4 has tumor suppressive effects in myeloma [38], and Tβ10 is deregulated in renal cell carcinoma [39] and ovarian cancer [40].